384 results on '"Wagner, Mathilde"'
Search Results
2. Association between preoperative appendiceal histology grade and Pseudomyxoma peritonei grade offers a solution to avoid right hemicolectomy during cytoreductive surgery and HIPEC
3. Detection and characterization of pancreatic lesion with artificial intelligence: The SFR 2023 artificial intelligence data challenge
4. Portal hypertension is associated with poorer outcome and clinical liver decompensation in patients with HCC treated with Atezolizumab-Bevacizumab
5. Active surveillance for low-grade appendiceal mucinous neoplasm (LAMN)
6. Splenic vein tumor thrombosis is a major prognostic factor in distal pancreatic adenocarcinoma
7. Appendiceal adenocarcinoma, diagnosed after acute perforated appendicitis: Potential contribution of HIPEC
8. Enhanced therapeutic outcomes with atezolizumab-bevacizumab and SIRT combination compared to SIRT alone in unresectable HCC: A promising approach for improved survival
9. Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively recruited cohort study (the LITMUS imaging study): Study protocol
10. Albumin infusion reduces ascite occurrence in Child-Pugh B patients treated by Atezolizumab-Bevacizumab for advanced HCC
11. THU-458 No correlation between MASLD and poor outcome of Atezolizumab-Bevacizumab therapy in patients with advanced HCC
12. OS-077 Added value of a combination of positron emission tomography with 18F-FDG and 18 F-Fluorocholine for staging optimization and treatment modification in patients with hepatocellular carcinoma: the prospective multicentric PET HCC01 study
13. Accuracy, repeatability, and interplatform reproducibility of T1 quantification methods used for DCE‐MRI: Results from a multicenter phantom study
14. Quantitative Elastography Methods in Liver Disease: Current Evidence and Future Directions.
15. Chylous Ascites After Gastric Bypass Surgery: a Feature of Mesenteric Torsion; Comment on: “Chyloperitoneum Due to Small Bowel Obstruction Following Laparoscopic Roux-en-Y Gastric Bypass: a Case Report and Review of Literature”
16. New frontiers in liver resection for hepatocellular carcinoma
17. Imaging of hepatocellular carcinoma: a pilot international survey
18. Splenic vein tumor thrombosis is a major prognostic factor in distal pancreatic adenocarcinoma
19. COVID-19 impact assessment on the French radiological centers: a nationwide survey
20. Ultrasound-detected connective tissue involvement in acute muscle injuries in elite athletes and return to play: The French National Institute of Sports (INSEP) study
21. No correlation between MASLD and poor outcome of Atezolizumab‐Bevacizumab therapy in patients with advanced HCC.
22. Active surveillance for low-grade appendiceal mucinous neoplasm (LAMN).
23. Portal‐hypertension features are associated with ascites occurrence and survival in patients with hepatocellular carcinoma treated by external radiotherapy
24. Impact of radiological response and pattern of progression in patients with HCC treated by atezolizumab-bevacizumab
25. LI-RADS pour le diagnostic de carcinome hépatocellulaire en TDM et IRM
26. Earlier Anti-Tumor Necrosis Factor Therapy of Crohn’s Disease Correlates with Slower Progression of Bowel Damage
27. MRI for prostate cancer: can computed high b-value DWI replace native acquisitions?
28. Tumor-size responses to first-line is a predictor of overall survival in metastatic colorectal cancer
29. 554: Clinical, dosimetric and radiomics features predictive of lung toxicity after (chemo)radiotherapy
30. Baveno VI and VII criteria are not suitable for screening for large varices or clinically significant portal hypertension in patients with hepatocellular carcinoma
31. Impact of radiological response and pattern of progression on overall survival in patients with hepatocellular carcinoma treated by atezolizumab-bevacizumab
32. Presence of esophageal varices regardless their size is associated with overall survival in patients with advanced HCC treated with Atezolizumab/Bevacizumab
33. Portal-hypertension parameters are associated with survival and ascites occurrence in patients with hepatocellular carcinoma treated by external radiotherapy
34. Liver Frailty Index is associated with progression-free survival in patients with advanced HCC treated with Atezolizumab/Bevacizumab
35. Baveno VI and VII criteria are not suitable for screening of large size esophageal varices and clinically significant portal hypertension in patients with HCC
36. Feasibility and reproducibility of liver surface nodularity quantification for the assessment of liver cirrhosis using CT and MRI
37. Treatment intensification with hepatic arterial infusion chemotherapy in patients with liver-only colorectal metastases still unresectable after systemic induction chemotherapy – a randomized phase II study -- SULTAN UCGI 30/PRODIGE 53 (NCT03164655)- study protocol
38. RECIST and CHOI criteria in the evaluation of tumor response in patients with metastatic colorectal cancer treated with regorafenib, a prospective multicenter study
39. Prediction of the histopathologic findings of intrahepatic cholangiocarcinoma: qualitative and quantitative assessment of diffusion-weighted imaging
40. Prediction of hepatocellular carcinoma response to 90Yttrium radioembolization using volumetric ADC histogram quantification: preliminary results
41. Appendiceal adenocarcinoma, diagnosed after acute perforated appendicitis : potential contribution of CHIP for 22 patients
42. Validation of a screening algorithm for hepatic fibrosis by Doppler ultrasound and elastography in a general population
43. Baseline ALBI score and early variation of serum AFP predicts outcomes in patients with HCC treated by atezolizumab–bevacizumab
44. Abdominal Extrarenal Involvement in Erdheim-Chester Disease in a Cohort of 304 Patients
45. Imaging-based surrogate markers of transcriptome subclasses and signatures in hepatocellular carcinoma: preliminary results
46. Outpatient Appendectomy in an Emergency Outpatient Surgery Unit 24 h a Day: An Intention-to-Treat Analysis of 194 Patients
47. CT evaluation after neoadjuvant FOLFIRINOX chemotherapy for borderline and locally advanced pancreatic adenocarcinoma
48. Value of tumor stiffness measured with MR elastography for assessment of response of hepatocellular carcinoma to locoregional therapy
49. Prediction of pancreatic neuroendocrine tumour grade with MR imaging features: added value of diffusion-weighted imaging
50. Correction to: Prediction of pancreatic neuroendocrine tumour grade with MR imaging features: added value of diffusion-weighted imaging
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.